Cytolytic virus activation therapy and treatment monitoring for Epstein‐Barr virus associated nasopharyngeal carcinoma in a mouse tumor model

Undifferentiated nasopharyngeal carcinoma (NPC) is 100% associated with Epstein‐Barr virus (EBV). Expression of viral proteins in the tumor cells is highly restricted. EBV reactivation by CytoLytic Virus Activation (CLVA) therapy triggers de novo expression of early viral kinases (PK and TK) and use...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Med Virol
Egile Nagusiak: Novalić, Zlata, Verkuijlen, Sandra A. W. M., Verlaan, Mariska, Eersels, Jos L. H., de Greeuw, Inge, Molthoff, Carla F. M., Middeldorp, Jaap M., Greijer, Astrid E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656928/
https://ncbi.nlm.nih.gov/pubmed/28853217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.24870
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak